Anne Prener

Insider Reports History

Entity
Individual
Location
C/O Rubius Therapeutics, 399 Binney Street Suite 300, Cambridge, MA
Signature
/s/ Jonathan Freve, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Prener:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rubius Therapeutics, Inc. Director Stock Option (Right to Buy) 25K May 12, 2022 Direct
Galecto, Inc. Director Stock Option (right to buy) 18K Jun 20, 2024 Direct
Kaleido Biosciences, Inc. Director Stock Option (Right to Buy) 15K Jun 30, 2021 Direct

Insider Reports Filed by Anne Prener

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLTO Galecto, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
GLTO Galecto, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
GLTO Galecto, Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
RUBY Rubius Therapeutics, Inc. May 12, 2022 1 $0 4 May 13, 2022 Director
KLDO Kaleido Biosciences, Inc. Jun 30, 2021 1 $0 4 Jul 1, 2021 Director
GLTO Galecto, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director
RUBY Rubius Therapeutics, Inc. May 12, 2021 1 $0 4 May 13, 2021 Director